Edition:
United Kingdom

Neptune Technologies & Bioressources Inc (NEPT.OQ)

NEPT.OQ on NASDAQ Stock Exchange Capital Market

2.81USD
20 Jul 2018
Change (% chg)

$-0.11 (-3.77%)
Prev Close
$2.92
Open
$2.92
Day's High
$2.94
Day's Low
$2.79
Volume
65,720
Avg. Vol
124,236
52-wk High
$4.46
52-wk Low
$0.70

Latest Key Developments (Source: Significant Developments)

Neptune Technologies Announces Research Agreement Aimed At Medical Cannabinoid-Based Products
Friday, 19 Jan 2018 

Jan 19 (Reuters) - Neptune Technologies & Bioressources Inc ::NEPTUNE ANNOUNCES RESEARCH AGREEMENT AIMED AT NEW MEDICAL AND WELLNESS CANNABINOID-BASED PRODUCTS.NEPTUNE TECHNOLOGIES & BIORESSOURCES-ANNOUNCED EXCLUSIVE RESEARCH AGREEMENT FOR DEVELOPING NEW MEDICAL, WELLNESS TARGETED CANNABINOID-BASED PRODUCTS​.NEPTUNE TECHNOLOGIES & BIORESSOURCES INC - ‍ REACHED THE EXCLUSIVE RESEARCH AGREEMENT WITH A KRILL OIL PROVIDER​.  Full Article

Neptune Technologies Extends Global Maxsimil Licence To Cannabis-Derived Products​
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Neptune Technologies & Bioressources Inc ::NEPTUNE TECHNOLOGIES & BIORESSOURCES - CO EXTENDS GLOBAL MAXSIMIL LICENCE TO CANNABIS-DERIVED PRODUCTS​.  Full Article

Neptune Q2 revenue C$6.8 million versus C$11.6 million
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Neptune Technologies & Bioressources Inc :Neptune announces second quarter results.Q2 revenue C$6.8 million versus C$11.6 million.Neptune Technologies & Bioressources Inc - ‍gain of $23.9 million realized from sale of Krill Oil business​.Neptune Technologies & Bioressources Inc - ‍net income was $20.0 million for quarter, versus a net loss of $0.7 million in prior year​.  Full Article

Neptune and Ingenutra signs exclusive worldwide agreement for MaxSimil
Friday, 7 Oct 2016 

Neptune Technologies & Bioressources Inc : Terms also cover potential collaboration between both companies on clinical trials . Neptune Technologies & Bioressources Inc says all other terms of agreement remain confidential . Neptune and Ingenutra sign an exclusive worldwide agreement for Maxsimil . All other terms of agreement remain confidential. . Agreement allows neptune to manufacture, distribute and sell Maxsimil in nutraceutical field worldwide .Says agreement is valid till 2028.  Full Article